A citation-based method for searching scientific literature

Ellen Warner, Kimberley Hill, Petrina Causer, Donald Plewes, Roberta Jong, Martin Yaffe, William D Foulkes, Parviz Ghadirian, Henry Lynch, Fergus Couch, John Wong, Frances Wright, Ping Sun, Steven A Narod. J Clin Oncol 2011
Times Cited: 154







List of co-cited articles
777 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
42

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Peter E Besnard, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Hans Peterse, Madeleine M A Tilanus-Linthorst,[...]. N Engl J Med 2004
35

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, A K Dixon, D F Easton, R A Eeles, D G R Evans, F J Gilbert, I Griebsch, R J C Hoff, P Kessar,[...]. Lancet 2005
687
31

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
29

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Ellen Warner, Donald B Plewes, Kimberley A Hill, Petrina A Causer, Judit T Zubovits, Roberta A Jong, Margaret R Cutrara, Gerrit DeBoer, Martin J Yaffe, Sandra J Messner,[...]. JAMA 2004
755
29

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
28

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay,[...]. Br J Cancer 2012
106
27

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Wendie A Berg, Zheng Zhang, Daniel Lehrer, Roberta A Jong, Etta D Pisano, Richard G Barr, Marcela Böhm-Vélez, Mary C Mahoney, W Phil Evans, Linda H Larsen,[...]. JAMA 2012
539
26

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Christiane K Kuhl, Simone Schrading, Claudia C Leutner, Nuschin Morakkabati-Spitz, Eva Wardelmann, Rolf Fimmers, Walther Kuhn, Hans H Schild. J Clin Oncol 2005
635
25

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Ellen Warner, Hans Messersmith, Petrina Causer, Andrea Eisen, Rene Shumak, Donald Plewes. Ann Intern Med 2008
321
25

Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI.
Christiane K Kuhl, Simone Schrading, Kevin Strobel, Hans H Schild, Ralf-Dieter Hilgers, Heribert B Bieling. J Clin Oncol 2014
264
24

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Christiane Kuhl, Stefanie Weigel, Simone Schrading, Birke Arand, Heribert Bieling, Roy König, Bernd Tombach, Claudia Leutner, Andrea Rieber-Brambs, Dennis Nordhoff,[...]. J Clin Oncol 2010
253
23

Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
129
23

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
22

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
695
22

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Francesco Sardanelli, Franca Podo, Filippo Santoro, Siranoush Manoukian, Silvana Bergonzi, Giovanna Trecate, Daniele Vergnaghi, Massimo Federico, Laura Cortesi, Stefano Corcione,[...]. Invest Radiol 2011
190
20

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
648
17


BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Adriana J Rijnsburger, Inge-Marie Obdeijn, Reinoutje Kaas, Madeleine M A Tilanus-Linthorst, Carla Boetes, Claudette E Loo, Martin N J M Wasser, Elisabeth Bergers, Theo Kok, Sara H Muller,[...]. J Clin Oncol 2010
110
16

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).
Sepideh Saadatmand, Inge-Marie Obdeijn, Emiel J Rutgers, Jan C Oosterwijk, Rob A Tollenaar, Gwendolyn H Woldringh, Elisabeth Bergers, Cornelis Verhoef, Eveline A Heijnsdijk, Maartje J Hooning,[...]. Int J Cancer 2015
48
33

MRI breast screening in high-risk women: cancer detection and survival analysis.
D Gareth Evans, Nisha Kesavan, Yit Lim, Soujanye Gadde, Emma Hurley, Nathalie J Massat, Anthony J Maxwell, Sarah Ingham, Rosalind Eeles, Martin O Leach,[...]. Breast Cancer Res Treat 2014
72
20


Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
482
13

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Eveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, Madeleine M A Tilanus-Linthorst, Gareth Evans, Petrina A Causer, Rosalind A Eeles, Reinie Kaas, Gerrit Draisma, Elizabeth A Ramsay,[...]. Cancer Epidemiol Biomarkers Prev 2012
51
25

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
328
13

Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Anna M Chiarelli, Maegan V Prummel, Derek Muradali, Vicky Majpruz, Meaghan Horgan, June C Carroll, Andrea Eisen, Wendy S Meschino, Rene S Shumak, Ellen Warner,[...]. J Clin Oncol 2014
60
20

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
12

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
472
12

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
11

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
861
11

Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Janice S Sung, Sarah Stamler, Jennifer Brooks, Jennifer Kaplan, Tammy Huang, D David Dershaw, Carol H Lee, Elizabeth A Morris, Christopher E Comstock. Radiology 2016
58
18

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
181
11

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
10

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
S A Narod, J S Brunet, P Ghadirian, M Robson, K Heimdal, S L Neuhausen, D Stoppa-Lyonnet, C Lerman, B Pasini, P de los Rios,[...]. Lancet 2000
383
10

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
912
10

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001
628
10

Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.
Anne I Hagen, Kjell Arne Kvistad, Lovise Maehle, Marit Muri Holmen, Hildegunn Aase, Bodil Styr, Anita Vabø, Jaran Apold, Per Skaane, Pål Møller. Breast 2007
117
10

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010
150
10

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012
319
10

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
994
10


Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Xuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, Ellen Warner, Francesco Sardanelli, Martin O Leach, Christopher C Riedl, Isabelle Trop, Maartje J Hooning, Rodica Mandel,[...]. Br J Cancer 2016
45
22

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
10


Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
L C Hartmann, T A Sellers, D J Schaid, T S Frank, C L Soderberg, D L Sitta, M H Frost, C S Grant, J H Donohue, J E Woods,[...]. J Natl Cancer Inst 2001
475
9

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
240
9

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.
C T Brekelmans, C Seynaeve, C C Bartels, M M Tilanus-Linthorst, E J Meijers-Heijboer, C M Crepin, A A van Geel, M Menke, L C Verhoog, A van den Ouweland,[...]. J Clin Oncol 2001
224
9

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.
Wendie A Berg, Jeffrey D Blume, Jean B Cormack, Ellen B Mendelson, Daniel Lehrer, Marcela Böhm-Vélez, Etta D Pisano, Roberta A Jong, W Phil Evans, Marilyn J Morton,[...]. JAMA 2008
792
9

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.
Jessica E Cott Chubiz, Janie M Lee, Michael E Gilmore, Chung Y Kong, Kathryn P Lowry, Elkan F Halpern, Pamela M McMahon, Paula D Ryan, G Scott Gazelle. Cancer 2013
42
21

Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
Pål Møller, Astrid Stormorken, Christoffer Jonsrud, Marit Muri Holmen, Anne Irene Hagen, Neal Clark, Anita Vabø, Ping Sun, Steven A Narod, Lovise Mæhle. Breast Cancer Res Treat 2013
31
29


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.